How Does Desloratadine Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Key Takeaways: How Desloratadine Works
- Active Ingredient: Desloratadine, a non‑sedating antihistamine (active metabolite of loratadine).
- Primary Action: Selective peripheral H1 receptor antagonist; blocks histamine to relieve sneezing, itching, and hives.
- Onset & Duration: Onset within 1 hour; effects last 24 hours allowing once‑daily dosing.
- Metabolism: Hepatic via CYP2C8/UGT2B10 to active metabolite 3‑hydroxydesloratadine; half‑life ~27 hours.
- CNS Penetration: Minimal – does not cause significant drowsiness.
Desloratadine is a modern antihistamine that provides effective relief from allergy symptoms without causing drowsiness by selectively blocking peripheral histamine receptors. Its pharmacokinetic profile ensures sustained 24‑hour control.
Important Medical Advice
If you experience signs of severe allergic reaction – difficulty breathing, swelling of the face/tongue/throat, severe itching or hives – stop taking Desloratadine and seek immediate medical attention. These reactions are very rare but require urgent care.
Chemical Composition & Molecular Structure
Desloratadine 5 mg tablets contain the active substance desloratadine, a tricyclic antihistamine. Each tablet includes 5 mg desloratadine and the following excipients: microcrystalline cellulose, lactose monohydrate, maize starch, colloidal anhydrous silica, and magnesium stearate.
Structural Details
8‑chloro‑6,11‑dihydro‑11‑(4‑piperidinylidene)‑5H‑benzo[5,6]cyclohepta[1,2‑b]pyridine
Molecular formula: C₁₉H₁₉ClN₂ · Molecular weight: 310.8 g/mol · LogP: 3.5 · pKa: 9.7
Key Pharmaceutical Properties
| Property | Desloratadine | 3‑Hydroxydesloratadine (active metabolite) |
|---|---|---|
| Lipophilicity (logP) | 3.5 | 2.8 |
| Protein binding | 82‑87% | 85% |
| Oral bioavailability | Proportional to dose | — |
| Receptor affinity | High (H1) | High (H1) |
🗒️ Pharmaceutical insight: The lactose content (approximately 58 mg per tablet) should be considered in patients with galactose intolerance.
Mechanism of Action: Desloratadine Pathway
Desloratadine exerts its antiallergic effects through two complementary mechanisms:
- H1 Receptor Antagonism: Desloratadine selectively binds to peripheral histamine H1 receptors, competitively inhibiting histamine. This prevents histamine‑mediated symptoms such as sneezing, itching, rhinorrhoea, and vasodilation. Its high selectivity for peripheral receptors and low penetration of the blood‑brain barrier explain its non‑sedating profile.
- Anti‑inflammatory Activity: In addition to receptor blockade, desloratadine inhibits the release of pro‑inflammatory cytokines (e.g., IL‑4, IL‑6, IL‑13) from mast cells and basophils, and downregulates adhesion molecule expression (ICAM‑1), reducing the recruitment of inflammatory cells.
| Feature | Desloratadine |
|---|---|
| Receptor target | Peripheral H1 receptor |
| Onset of action | 1 hour |
| Duration of action | 24 hours |
🗒️ Physiological insight: Unlike first‑generation antihistamines, desloratadine’s polar structure limits CNS entry, preserving alertness.
Absorption & Distribution (Pharmacokinetics)
Desloratadine is rapidly and well absorbed after oral administration. Peak plasma concentrations are reached approximately 3 hours post‑dose. Food does not affect bioavailability.
Absorption
Absolute bioavailability is dose‑proportional. Desloratadine is not subject to extensive first‑pass metabolism; the active metabolite 3‑hydroxydesloratadine appears in plasma.
Distribution
Volume of distribution averages 49 L, indicating moderate tissue distribution. Plasma protein binding is 82‑87%. Desloratadine does not readily cross the blood‑brain barrier.
Metabolic Effects & Elimination
Metabolism: Desloratadine is extensively metabolised in the liver, primarily by CYP2C8 and UGT2B10, to its active metabolite 3‑hydroxydesloratadine. This metabolite retains pharmacological activity and contributes to the overall effect.
Elimination: Approximately 40% of a dose is excreted in urine (as metabolites) and 40% in faeces. The terminal elimination half‑life of desloratadine is about 27 hours, and that of 3‑hydroxydesloratadine is approximately 37 hours, supporting once‑daily dosing.
⚠️ Metabolic caution: In patients with severe hepatic impairment, systemic exposure may be increased; a lower starting dose is recommended by some guidelines.
Clinical Efficacy in Allergy Management
Desloratadine is indicated for symptomatic relief of allergic rhinitis (including intermittent and persistent) and urticaria in adults and adolescents aged 12 years and older.
- Allergic rhinitis: Reduces sneezing, rhinorrhoea, nasal congestion, nasal itching, and ocular symptoms. Onset of relief occurs within 1 hour, and efficacy is maintained over 24 hours.
- Urticaria: Significantly reduces itching, number and size of hives, and associated discomfort.
In clinical trials, desloratadine improved quality of life scores and sleep parameters compared to placebo. Its non‑sedating profile ensures patients can resume normal activities.
Desloratadine FAQs
How long does desloratadine take to work?
Desloratadine starts working within 1 hour of taking a dose, providing rapid relief from allergy symptoms.
Can I take desloratadine with other medicines?
No clinically significant drug interactions have been reported. However, always inform your doctor or pharmacist about all medications you take.
Is desloratadine safe for long‑term use?
Yes, desloratadine is well‑tolerated for prolonged periods. Your doctor will advise on the appropriate duration based on your condition.
Does desloratadine cause drowsiness?
At recommended doses, desloratadine is non‑sedating. Very rarely, some individuals may experience fatigue, but it does not impair alertness in most people.
What should I do if I miss a dose?
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose – do not double up.
Need Desloratadine for Allergy Relief?
If you suffer from hay fever or hives, a UK‑registered doctor can assess your symptoms and prescribe desloratadine online.
Secure Prescription & Next-Day Delivery
MHRA‑compliant | GPhC‑registered pharmacy | Discreet packaging | UK‑registered doctors
Start Allergy ConsultationRelated Desloratadine Guides
Clinical References & Sources
Medical Content Manager
Nabeel is a co‑founder and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up‑to‑date.
Medical Doctor
Dr. Feroz is a GMC‑registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co‑founder and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 11 March 2026
Next Review: 11 September 2026
Published on: 11 March 2026
Last Updated: 11 March 2026